SN
ACHV icon

Sittner & Nelson’s Achieve Life Sciences ACHV Stock Holding History

Sittner & Nelson’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39K Hold
673
– – ﹤0.01% 499
2026
Q1 		$1.98K Hold
673
– – ﹤0.01% 517
2025
Q4 		$2.86K Hold
673
– – ﹤0.01% 464
2025
Q3 		$2.12K Buy
+673
New +$1.85K ﹤0.01% 441

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sittner & Nelson's ACHV Position: Q2 2026 in Review

Sittner & Nelson held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 673 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Sittner & Nelson first reported a position in ACHV in Q3 2025 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Sittner & Nelson held 673 shares of Achieve Life Sciences worth $4.39K as of Q2 2026.
  • Sittner & Nelson left its Achieve Life Sciences share count unchanged in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Sittner & Nelson's portfolio in Q2 2026, its #499 holding.
  • Sittner & Nelson first reported a position in Achieve Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.